Venture startup

Who invested in PatientSource Ltd.

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Cloud

Funding summaryUpdated 26 Oct 2026

$414Kraised across 1 round since 2018, from 1 source

Latest round
Venture, $414KApr 2018
Investors
1
See who backed them

The rounds

  1. Apr 2018
    Venture$414K

    Source recorded

Funding filed with regulators

PatientSource Ltd. filed 3 raises, $869K in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Sept 2024$160KUK share allotment
  2. Feb 2023$163KUK share allotment
  3. Feb 2022$547KUK share allotment

Founders and team

From PatientSource Ltd.'s own website: 1 founder, 4 on the team.

Lee FrancisCo-founder - Sales, Marketing and Partnerships Director
  • Daniel BuckleyHead of Marketing
  • Alison TantTechnical Configuration Analyst
  • Cheryl LewisProgramme Manager
  • Nick JenveyPerformance and Reporting Lead

Everyone who backed them

Cambridge AngelsAngel network1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about PatientSource Ltd.

Who invested in PatientSource Ltd.?

PatientSource Ltd.'s investors include Cambridge Angels.

How much has PatientSource Ltd. raised?

PatientSource Ltd. has raised $414K across 1 round since 2018.

When did PatientSource Ltd. last raise?

PatientSource Ltd.'s most recent round was a Venture of $414K in Apr 2018.

What was PatientSource Ltd.'s biggest round?

Its most recent round, $414K in Apr 2018, is also its largest on record.

Who backed PatientSource Ltd. first?

PatientSource Ltd.'s first round on record, in Apr 2018, was backed by Cambridge Angels.

What stage is PatientSource Ltd. at?

PatientSource Ltd.'s latest named round is a Venture, in Apr 2018.

Companies like PatientSource Ltd.

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.